HIGHLIGHTS
- who: Muhammad Saleem et al. from the (UNIVERSITY) have published the research: Clinical and biochemical outcomes of Sodium-Glucose CoTransporter-2 (SGLT2) Inhibitors in Type-2 Diabetes_Mellitus Patients as fourth oral anti diabetic medicine, in the Journal: (JOURNAL) of December/31,/2020
- what: The Objective of the study was to evaluate the clinical and biochemical effects of_(SGLT2) inhibitors as a fourth oral anti-diabetic drug in patients with Type-2 diabetes_mellitus (T2DM). The study has shown similar results with HbA1c levels being significantly reduced at 3 months and 6 months follow up with mean . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.